Name: 2023 American Cough Conference
Start: 09/06/2023 11:15 AM +00:00
End: 10/06/2023 08:00 PM +00:00

Merck DSA Product Theater

Bellus Health

Merck

Trevi Therapeutics

The American Cough Conference is the world's leading educational meeting for health care professionals involved in the research and management of patients with cough. The 2021 conference was held virtually due to the COVID pandemic with all the same state-of-the-art updates, networking opportunities and interaction with the Who's Who of Cough. We had an exceptional group of speakers who delivered live content with audience interaction.&nbsp;
We look forward to the Ninth American Cough Conference, in person, June 9-10, 2023 at the Sheraton Reston Hotel, Reston, Virginia.

American Cough Conference 2023

Reckitt

Boehringer Ingelheim

Our Mission is to improve patient lives by designing and manaufacturing market leading product and services.
We have decades of expeerience in the manufacture and supply of respiratory diagnostic devices trusted by both medical professionals and patients alike.
Our intention is to have a real impact in the effective management of respiratory diseases. We provide a wide varitety of precise, intuitive devices for respiratory care including spirometers, lung and asthma monitors, COPD screeners, medical workstations as well as software consumables.

Mark Russell

NeRRe is developing orvepitant, a neurokinin(NK)-1 receptor antagonist, as a first in class, once daily breakthrough treatment for cough hypersensitivity disorders. Having demonstrated proof of efficacy in patients with refractory or unexplained cough, NeRRe will now continue development in chronic cough caused by the rare and terminal lung disease idiopathic pulmonary fibrosis (IPF). A dominant feature of this severe progressive respiratory disease in a high proportion of patients is an uncontrolled and persistent cough which is disabling for these terminally ill patients. The cough is often refractory to medical therapy and there are no approved treatments for it. Idiopathic pulmonary fibrosis has been designated and orphan disease in both Europe and the USA.

NeRRe Therapeutics

Algernon Pharmaceuticals

8:00 &nbsp; Chairman&rsquo;s Welcome &ndash; Peter Dicpinigaitis
&nbsp;
Session 1 &ndash; Emerging Concepts in Cough
8:10&nbsp; &nbsp; &nbsp;Illuminating airway afferent nerve remodeling in chronic cough. &ndash; Matthew Drake
8:35&nbsp; &nbsp; &nbsp;Placebo effect: learnings from pain studies. &ndash; Nathanial Katz
9:00&nbsp; &nbsp; &nbsp;The importance of cough in IPF and ILD. &nbsp;&ndash; Steven Nathan
9:25&nbsp; &nbsp; &nbsp; Potential mechanisms underlying IPF cough. &ndash; Brendan Canning

Peter Dicpinigaitis

Matthew Drake

Nathaniel Katz

Steven Nathan

Brendan Canning

Session 1- Emerging Concepts in Cough

10:10&nbsp; &nbsp;The dependence of chronic cough on hydration of the larynx and trachea by divalent salts. &ndash; David Edwards
10:35&nbsp; &nbsp;Cough and asthma: what have we been missing? &ndash; Lorcan McGarvey
11:00 &nbsp; CANVAS Syndrome: a neuropathic cause of chronic cough &nbsp;&ndash; Surinder Birring
11:25 &nbsp; Viral mechanisms of cough hypersensitivity. &ndash; Stuart Mazzone&nbsp;

David Edwards

Lorcan McGarvey

Surinder Birring

Stuart Mazzone

Session 2- Mechanisms and Diagnosis

13:05&nbsp; &nbsp;Cough counting technology - Update. &ndash; Peter Small
13:30 &nbsp; Clinical Cough Monitoring: Past, Present, Future. &ndash;&nbsp; Frank Keane&nbsp;
13:55 &nbsp; The science and place of Cough-omics in chronic cough &ndash;&nbsp; K. Fan Chung
14:20 &nbsp; The role of the Speech-Language Pathologist in the management of refractory chronic cough. &ndash; Laurie Slovarp

Peter Small

Frank Keane

Fan Chung

Laurie Slovarp

Session 3- Chronic Cough Evaluation and Management

Oral Abstracts

Alyn Morice

Jacky Smith

Mikhail Kalinichev

Carmen La Rosa

Catherine Bonuccelli

Steve Pawsey

Christopher Silber

Juan Carlos Gomez

Christopher Bryan

Michael Kitt

Thomas Sciascia

American Cough Conference colors

English

America/New_York

I agree to the <a href="https://legal.hubilo.com/terms/13570" target="_blank">Terms and Conditions</a> and <a href="https://legal.hubilo.com/privacy/13570" target="_blank">Privacy Policy</a>.

Registration for the IN-PERSON event includes:
* Access to the  interactive conference program.
* Access to the virtual platform 
* Access to recordings of sessions on the platform for up to 30 days after the event
* Access to session recordings for 1 year, links to be provided.
* Entry to all conference sessions 
* Conference materials
* Certificate of Attendance, by request
* Buffet breakfast, Coffee Breaks and a boxed or buffet lunch on both days of the conference

In-person after March 1, 2023

Registration for the IN-PERSON event includes:
* Access to the event app interactive conference program.
* Access to the virtual platform 
* Access to recordings of sessions on the platform for up to 30 days after the event
* Access to session recordings for 1 year, links to be provided.
* Entry to all conference sessions, the exhibition and poster area 
* Conference materials
* Certificate of Attendance
* Buffet breakfast, Coffee Breaks and a boxed or buffet lunch on both days of the conference

Allied Health / Residents / Students In-Person

Registration for the VIRTUAL event includes access to the event platform where you will view the event in real time, submit questions to presenters, view recordings of sessions on the platform for 30 days and access to recordings for 1 year.

VIRTUAL

Allied Health / Residents / Students VIRTUAL 